Status:
COMPLETED
Effect of Rapid Rollover on Pneumothorax After CT-Guided Lung Biopsy
Lead Sponsor:
University of California, San Francisco
Conditions:
Lung Cancer
Pneumothorax
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Pneumothorax is the most common complication after CT-guided lung biopsy, and several techniques have been proposed to reduce the risk. Among them, rapid rollover is the maneuver to immediately reposi...
Detailed Description
All patients will undergo CT-guided lung biopsy by the best approach decided by the primary operator. Randomization will be performed based on parity of patients' medical record numbers, which were as...
Eligibility Criteria
Inclusion
- All patients who are referred to the Department of Radiology and Biomedical Imaging Cardiac and Pulmonary Imaging section for CT-guided lung biopsy will be screened for eligibility. All eligible patients will be enrolled. Patients who develop intra-procedural pneumothorax will be analyzed but excluded from the final analysis.
Exclusion
- Patients with chest wall, subpleural or mediastinal lesions
- Patients who develop intra-procedural pneumothorax
- Patients who are biopsied by a prone approach
- Patients who are repositioned intra-procedurally
- Patients who are unable to tolerate reposition or have spinal precautions
- Patients who develop hemothorax and a chest tube is inserted for this indication
Key Trial Info
Start Date :
September 15 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2024
Estimated Enrollment :
54 Patients enrolled
Trial Details
Trial ID
NCT05342675
Start Date
September 15 2022
End Date
June 30 2024
Last Update
June 12 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Zuckerberg San Francisco General Hospital and Trauma Center
San Francisco, California, United States, 94110
2
University of California, San Francisco
San Francisco, California, United States, 94143